Cargando…
Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry
Although numerous patient‐specific co‐factors have been shown to be associated with worse outcomes in COVID‐19, the prognostic value of thalassaemic syndromes in COVID‐19 patients remains poorly understood. We studied the outcomes of 137 COVID‐19 patients with a history of transfusion‐dependent thal...
Ejemplares similares
-
Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
por: Origa, Raffaella, et al.
Publicado: (2022) -
Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Authors’ Reply
por: Marhaeni, Wulandewi, et al.
Publicado: (2021) -
COVID 19 and Hemoglobinopathies: Update of the Italian Experience
por: Motta, Irene, et al.
Publicado: (2020) -
Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia
por: Marhaeni, Wulandewi, et al.
Publicado: (2021) -
Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
por: Carsetti, Rita, et al.
Publicado: (2022)